[Current status of the therapy of malignant testicular tumors].
Hecht
T
T
Medizinische Klinik, Universität Freiburg.
Thriemer
M
M
Arnold
H
H
Dölken
G
G
Sommerkamp
H
H
Wannenmacher
M
M
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002822:Choriocarcinoma / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004407:Dysgerminoma / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008297:Male; D009362:Neoplasm Metastasis; D009919:Orchiectomy; D011379:Prognosis; D011879:Radiotherapy Dosage; D013724:Teratoma / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D013736:Testicular Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D014747:Vinblastine / Q000008:administration & dosage
D014747:Vinblastine; D005047:Etoposide; D002945:Cisplatin
Derzeitiger Stand der Therapie maligner Hodentumoren.